Insmed's treatment-resistant lung disease drug gets FDA approval

The U.S. Food and Drug Administration on Friday approved Insmed Inc's lead drug to treat a rare, chronic lung disease, making it the first approved treatment in the United States for the condition.

from Reuters: Health https://ift.tt/2xLQNTT
via IFTTT

• Tweet
• Share
• Share
• Share
• Share